Analysts at Cantor Fitzgerald reiterated their "neutral" rating on Rivian (RIVN-0.20%) stock on Sept. 28. Curiously, however, ...

Viking Therapeutics tested various doses of its leading anti-obesity candidate, VK2735, administered subcutaneously every ...

Netflix (NFLX-1.02%) went public in May 2002, with its initial public offering (IPO) priced at $15 a share. It was a ...

Uber Technologies (UBER-0.97%) has become an unlikely value stock. Analysts anticipate 11% sales growth this year, followed ...

Cal-Maine Foods ( CALM -0.71%) didn't exactly lay an egg with its latest set of quarterly results, but investors didn't find ...

Anthropic is spending heavily on compute; its success will hinge on its revenue growth staying ahead of its expenses.

The core Personal Consumption Expenditures (PCE) price index rose 0.2% in August, less than economists expected.

Johnson & Johnson ( JNJ -0.54%) seems to be firing on all cylinders. The company's financial results have been strong this ...

Since its inception nearly 15 years ago, the Schwab U.S. Dividend Equity ETF has returned 13.2% annually. That's no guarantee ...

Generally speaking, it's a good idea to maintain cash reserves that can cover one to three years of living costs in ...

The SEC opened a five-year test lane for blockchain stock trading. Most investors can watch this experiment from the ...

Vanguard has become synonymous with indexing, low expense ratios, and exchange-traded funds (ETFs). It is the largest ...